Exane Derivatives’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-190
| Closed | -$50.8K | – | 705 |
|
2020
Q1 | $50.8K | Sell |
190
-750
| -80% | -$201K | 0.01% | 332 |
|
2019
Q4 | $331K | Sell |
940
-1,063
| -53% | -$374K | 0.06% | 194 |
|
2019
Q3 | $547K | Buy |
2,003
+893
| +80% | +$244K | 0.1% | 152 |
|
2019
Q2 | $592K | Sell |
1,110
-309
| -22% | -$165K | 0.1% | 144 |
|
2019
Q1 | $715K | Buy |
+1,419
| New | +$715K | 0.14% | 126 |
|